These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31043794)

  • 1. Aberrant expression of PAFAH1B3 associates with poor prognosis and affects proliferation and aggressiveness in hypopharyngeal squamous cell carcinoma.
    Xu J; Zang Y; Cao S; Lei D; Pan X
    Onco Targets Ther; 2019; 12():2799-2808. PubMed ID: 31043794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of S100A4 Predicts Migration, Invasion, and Poor Prognosis of Hypopharyngeal Squamous Cell Carcinoma.
    Xu J; Gross N; Zang Y; Cao S; Yang F; Yang Z; Yu W; Lei D; Pan X
    Mol Diagn Ther; 2019 Jun; 23(3):407-417. PubMed ID: 30868407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Expression of PAFAH1B3 Affects Proliferation and Apoptosis in Osteosarcoma.
    Fan J; Yang Y; Qian JK; Zhang X; Ji JQ; Zhang L; Li SZ; Yuan F
    Front Oncol; 2021; 11():664478. PubMed ID: 34136395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxM1 overexpression promotes cell proliferation and migration and inhibits apoptosis in hypopharyngeal squamous cell carcinoma resulting in poor clinical prognosis.
    Chen Y; Liu Y; Ni H; Ding C; Zhang X; Zhang Z
    Int J Oncol; 2017 Oct; 51(4):1045-1054. PubMed ID: 28848994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDCA3 promotes the proliferation and migration of hypopharyngeal squamous cell carcinoma cells by activating the Akt/mTOR pathway.
    Wu J; Cui M; Wang J; Fan J; Liu S; Lou W
    Biotechnol Genet Eng Rev; 2024 Oct; 40(2):707-725. PubMed ID: 36892980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of PD-L1 Expression and Its Tumor-Intrinsic Functions in Hypopharyngeal Squamous Cell Carcinoma.
    Cui P; Jing P; Liu X; Xu W
    Cancer Manag Res; 2020; 12():5893-5902. PubMed ID: 32765090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch1 serves as a prognostic factor and regulates metastasis via regulating EGFR expression in hypopharyngeal squamous cell carcinoma.
    Tian J; Liu X; Liu X; Jing P; Sa N; Wang H; Xu W
    Onco Targets Ther; 2018; 11():7395-7405. PubMed ID: 30425527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant GRK6 promoter methylation is associated with poor prognosis in hypopharyngeal squamous cell carcinoma.
    Qiu X; Chen J; Zhang Z; You Y; Wang Z
    Oncol Rep; 2016 Feb; 35(2):1027-33. PubMed ID: 26718636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of BTF3 affects the proliferation, apoptosis, and cell cycle regulation in hypopharyngeal squamous cell carcinoma.
    Zhang Y; Gross N; Li Z; Yin G; Zhong Q; Liu C; Huang Z
    Biomed Pharmacother; 2019 Oct; 118():109211. PubMed ID: 31404775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of up-regulation of circMATR3 on the proliferation, metastasis, progression and survival of hypopharyngeal carcinoma.
    Wang Z; Wei P; Wei D; Cao S; Liu H; Chen L; Han X; Zhao X; Liu C; Li G; Yang J; Pan X; Lei D
    J Cell Mol Med; 2020 Apr; 24(8):4687-4697. PubMed ID: 32166857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-204 is associated with poor prognosis and promotes cell proliferation in hypopharyngeal squamous cell carcinoma (HSCC).
    Zhou J; Ke Z; Ma L; Liu M; Zhang W
    Int J Clin Exp Pathol; 2017; 10(7):7968-7974. PubMed ID: 31966648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of AIM2 combined with high expression of p‑STAT3 is associated with poor prognosis in hypopharyngeal squamous cell carcinoma.
    Li Z; Shi X; Li H; Wang W; Li X
    Oncol Rep; 2019 Apr; 41(4):2396-2408. PubMed ID: 30816544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCDH20 acts as a tumour-suppressor gene through the Wnt/β-catenin signalling pathway in hypopharyngeal squamous cell carcinoma.
    Gong Z; Hu G
    Cancer Biomark; 2019; 26(2):209-217. PubMed ID: 31450490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated O-GlcNAcylation Promotes Malignant Phenotypes of Hypopharyngeal Squamous Cell Carcinoma by Stabilizing Nrf2 through Regulation of the PI3K/Akt Pathway.
    Dai W; Jin X; Jiang B; Chen W; Ji Z; Xu X; Tang M; Dai K; Han L
    Anticancer Agents Med Chem; 2020; 20(16):1933-1942. PubMed ID: 32538734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA HOXA11-AS Promotes Proliferation and Migration via Sponging miR-155 in Hypopharyngeal Squamous Cell Carcinoma.
    Xu J; Bo Q; Zhang X; Lei D; Wang J; Pan X
    Oncol Res; 2020 May; 28(3):311-319. PubMed ID: 31987067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.
    Liu X; Zhao W; Wang X
    Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of long noncoding RNA PEG10 promotes proliferation, invasion and metastasis of hypopharyngeal squamous cell carcinoma.
    Zhao M; Sun D; Li X; Xu Y; Zhang H; Qin Y; Xia M
    Oncol Lett; 2017 Sep; 14(3):2919-2925. PubMed ID: 28928830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALAT1 knockdown inhibits hypopharyngeal squamous cell carcinoma malignancy by targeting microRNA-194.
    Wang H; Wang F; Ouyang W; Jiang X; Li W
    Oncol Lett; 2020 Jul; 20(1):173-182. PubMed ID: 32565945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma.
    Tang S; Ni J; Chen B; Sun F; Huang J; Ni S; Tang Z
    BMC Cancer; 2022 May; 22(1):525. PubMed ID: 35534807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AB209630, a long non-coding RNA decreased expression in hypopharyngeal squamous cell carcinoma, influences proliferation, invasion, metastasis, and survival.
    Zhou J; Li M; Yu W; Li W; Wang J; Xiang X; Li G; Pan X; Lei D
    Oncotarget; 2016 Mar; 7(12):14628-38. PubMed ID: 26895099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.